The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of adjuvant targeted and anti-PD1 immunotherapy in BRAF-mutated stage III cutaneous melanoma: Retrospective, single center cohort study.
 
Angelina Akhmetianova
Honoraria - BIOCAD
 
Kristina V. Orlova
Honoraria - BIOCAD; Merck Serono; Novartis; Pierre Fabre; Roche; Swixx BioPharma
Speakers' Bureau - BIOCAD; Merck Serono; Novartis; Roche
Research Funding - BIOCAD; BIOCAD (Inst); ICON Clinical Research; Novartis (Inst)
Expert Testimony - BIOCAD; Sanofi/Regeneron
 
Valery V. Nazarova
Honoraria - BIOCAD
Speakers' Bureau - Novartis
 
Kirill A. Baryshnikov
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Igor Samoylenko
Honoraria - BIOCAD; Novartis; Pierre Fabre; R-Pharm; Roche; Swixx BioPharma
Speakers' Bureau - BIOCAD; Novartis; Pierre Fabre; Roche; Swixx BioPharma
Research Funding - BIOCAD; Novartis; R-Pharm
Expert Testimony - R-Pharm; Sanofi/Regeneron
 
Kirill Ivanilov
Honoraria - BIOCAD
 
Lev V. Demidov
Honoraria - BIOCAD; Novartis; Pierre Fabre; R-Pharm; Swixx BioPharma
Consulting or Advisory Role - BIOCAD
Speakers' Bureau - BIOCAD; Novartis; Pierre Fabre; Swixx BioPharma
Research Funding - BIOCAD
Expert Testimony - BIOCAD